A cancer screening program in Arizona that offers the Galleri blood test to first responders provides some insight into how well the test can catch cancers in this high-risk group.
Radiation-induced sarcoma (RIS) is a rare but aggressive complication of radiotherapy. This study was published as a preprint and has not yet been peer reviewed.
The rEECur international collaboration has helped answer questions about the best approach to treating a rare disease for which randomized trials were previously lacking.